Sovenyr
Get early access
Signal
2026-07-24
EPO Patents
[EPO] GENE EDITING SYSTEMS FOR TREATING AND PREVENTING FGF14 GAA CEREBELLAR ATAXIAS
Part of
Novel Neurotherapeutic Approaches And Models
Open primary source
See the whole picture